Untitled case
Final Written Decision- Docket:
- IPR2022-00190
An IPR proceeding before the PTAB against Osteomed LLC, resulting in a Final Written Decision.
Defendant
1 case as defendant.
Osteomed LLC is a medical device manufacturer specializing in orthopaedic fixation, surgical implants, and powered surgical instruments. Founded in 1988, the company's world headquarters and manufacturing facility are located in Dallas, Texas. Osteomed LLC operates as a wholly-owned subsidiary of Acumed LLC, which is part of Colson Medical, a Berkshire Hathaway company. The company has an estimated annual revenue of $50M-$100M and approximately 475 employees.
The company's product lines are focused on improving patient care through innovative orthopaedic solutions. These include craniofacial titanium fixation, small bone drills and saws, and a variety of implantable devices used in neurosurgery, reconstructive plastic surgery, oral surgery, podiatry, and foot and ankle orthopedics. Specific offerings include surgical implants, orthognathic implants, stents, modular surgical handpiece systems, and systems like the ExtremiLOCK Foot and ExtremiLOCK Ankle. Osteomed also provides orthobiologics, such as allografts and amniotic membranes, to aid in bone and soft tissue healing.
Osteomed LLC's patent litigation posture indicates it is an operating company defending its intellectual property. The company has appeared as a defendant in one tracked case at the Patent Trial and Appeal Board (PTAB). This aligns with public records showing Osteomed LLC as a patent owner whose patents have been challenged in inter partes reviews (IPRs) by entities like Stryker Corporation and Wright Medical Technology, Inc.
Notably, Osteomed LLC has been involved in several prominent PTAB proceedings and subsequent appeals to the U.S. Court of Appeals for the Federal Circuit. These cases often concern the validity of patents covering orthopaedic fixation technology, specifically bone plates with transfixation screw holes used in joint fusion surgery. Outcomes have been varied, with the Federal Circuit sometimes affirming, reversing, or remanding decisions regarding the patentability of Osteomed's claims.
An IPR proceeding before the PTAB against Osteomed LLC, resulting in a Final Written Decision.